SC

Stephane Ciblat

VU Ventus Therapeutics U.S.: 4 patents #2 of 7Top 30%
OP Oric Pharmaceuticals: 1 patents #1 of 17Top 6%
SP Syros Pharmaceuticals: 1 patents #1 of 5Top 20%
📍 Montréal, CA: #21 of 784 inventorsTop 3%
Overall (2025): #14,646 of 469,880Top 4%
6
Patents 2025

Issued Patents 2025

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12410167 Pyridazine compounds for inhibiting NLRP3 Stéphane Dorich, Jason Burch, Miguel St-Onge, Amandine CHEFSON, Alexandre Cote +1 more 2025-09-09
12398136 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors Stéphane Dorich 2025-08-26
12331048 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors Stéphane Dorich 2025-06-17
12312339 Polo like kinase 4 inhibitors Chudi Ndubaku, Jared MOORE, Paul Gibbons, Jae Hyuk CHANG, F. Anthony Romero +11 more 2025-05-27
12312351 Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors Stéphane Dorich 2025-05-27
12240869 Inhibitors of cyclin-dependent kinase 7 (CDK7) Jason J. Marineau, Michael Bradley, Claudio Edmundo Chuaqui, Anzhelika Kabro 2025-03-04